O&G SAQs · Early pregnancy care
Pregnancy after loss — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on pregnancy after loss: the obstetric and psychological risks that distinguish it from routine pregnancy, the operational components of care, mental health screening with the PASS and EPDS, the interpregnancy interval evidence, and the honest framing of the progesterone evidence after PRISM and PROMISE. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the named risk, the named tool, the absolute number, the trial name, the honest framing of the evidence. Answer the sub-part you are asked. [1]
Reveal model answer and mark schemeShowHide
(a) Pregnancy after loss as a distinct entity (3 marks)
One mark for the obstetric risks; one for the psychological risks; one for the framing stance. [1][3]
- Obstetric risks: miscarriage — especially recurrent miscarriage — is a sentinel marker for later obstetric risk including preterm birth, fetal growth restriction, abruption and stillbirth. This is therefore a higher-risk pregnancy, not a routine one.[1]
- Psychological risks: pregnancy-specific anxiety, anniversary reactions at the gestation of the previous loss, emotional cushioning (withholding attachment as self-protection), and a measurable rate of PTSD that does not resolve just because she is pregnant again.[3]
- The framing stance: this is a distinct clinical entity needing continuity of carer, additional surveillance, mental health screening, and a plan for the anniversary gestation — not a routine pregnancy with a footnote in the history.[1][3]
(b) Operational components of pregnancy-after-loss care (5 marks)
One mark per correctly specified component. [1][3]
- Continuity of carer — a named clinician and a named midwife from booking to postnatal.
- An early reassurance scan at the first contact, then additional scans at agreed milestones — including the gestation of the previous losses.
- A mental health screen at every contact using a validated tool, with a clear pathway to perinatal mental health for those who screen positive.
- Fetal movement advice individualised to the woman, with an explicit plan for what to do if she is worried.
- A documented plan for the anniversary gestation — what she will be offered, when, and by whom — and a planned, structured discharge at the end rather than a drift out of care.[1][3]
(c) Mental health screening (3 marks)
One mark for naming both tools; one for the comparative performance; one for what to do with the result. [3][4]
- I would screen with the Edinburgh Postnatal Depression Scale (EPDS) for depression and the Perinatal Anxiety Screening Scale (PASS) for anxiety, at booking and at every contact through the pregnancy.
- The rationale for using both: at its optimal cut-off the PASS identified 68% of women with a diagnosed anxiety disorder, compared with 36% detected by the EPDS anxiety subscale (Somerville 2014). Using the EPDS alone misses anxiety.[4]
- I would also screen explicitly for post-traumatic stress symptoms tied to the previous loss, and ask directly about self-harm and suicidal ideation at every contact, documenting the answer and acting the same day where indicated.[3]
(d) Interpregnancy interval (2 marks)
One mark for the position; one for the numbers. [5]
- There is no evidence-based reason to make her wait six months before conceiving after a miscarriage. The older advice is obsolete.
- The Kangatharan meta-analysis of over one million women found that conceiving within six months of a miscarriage was not associated with adverse outcomes, and was associated with lower risks of further miscarriage (RR 0.82, 95% CI 0.78 to 0.86) and preterm delivery (RR 0.79, 95% CI 0.75 to 0.83).[5]
(e) Progesterone evidence (2 marks)
One mark for the trial result; one for the honest framing. [6]
- PROMISE (836 women with unexplained recurrent miscarriage, NEJM 2015) found no significant difference in live birth between progesterone (65.8%) and placebo (63.3%) — relative rate 1.04 (95% CI 0.94 to 1.15).
- I would frame progesterone honestly: it did not significantly increase live birth in unexplained recurrent miscarriage, and I would not offer it as a certainty. If she still wishes to take it, I would discuss the evidence and document the shared decision.[6]
References6ShowHide
- [1]Quenby S, Gallos ID, Dhillon-Smith RK, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet, 2021.PMID 33915094
- [2]Coomarasamy A, Dhillon-Smith RK, Papadopoulou A, et al. Recurrent miscarriage: evidence to accelerate action. Lancet, 2021.PMID 33915096
- [3]Farren J, Jalmbrant M, Ameye L, et al. Post-traumatic stress, anxiety and depression following miscarriage or ectopic pregnancy: a prospective cohort study. BMJ Open, 2016.PMID 27807081
- [4]Somerville S, Dedman K, Hagan R, et al. The Perinatal Anxiety Screening Scale: development and preliminary validation. Arch Womens Ment Health, 2014.PMID 24699796
- [5]Kangatharan C, Labram S, Bhattacharya S. Interpregnancy interval following miscarriage and adverse pregnancy outcomes: systematic review and meta-analysis. Hum Reprod Update, 2017.PMID 27864302
- [6]Coomarasamy A, Williams H, Truchanowicz E, et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages (PROMISE). N Engl J Med, 2015.PMID 26605928